TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic Subdural HematomaHemorrhage Brain

Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to evaluate the function of matched pair Aristotle 14 Guidewire and Plato Microcatheter in MMA embolization treatment for chronic subdural hematoma compared to surgeon's preference

Sponsor: Ohio State University

You may qualify if…

  • Age ≥ 18 years old
  • Patient or legally authorized representative (LAR) signs an informed consent form
  • Confirmed diagnosis of subacute or chronic subdural hematoma, defined as 50% or more chronic blood
  • Pre-morbid Modified Rankin Score of ≤ 3

You may not qualify if…

  • Age \< 18 years old
  • Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization
  • Unmanaged, uncontrolled bleeding disorders/blood diathesis
  • Presumed septic embolus, or suspicion of microbial superinfection
  • Contraindication to angiography
  • CT or MRI evidence of intra-cranial tumor or mass lesion

Where it's recruiting

Ohio

Columbus

Source: ClinicalTrials.gov · NCT07324551 · last updated 2026-01-07